ng-nitroarginine methyl ester has been researched along with Cardiac Remodeling, Ventricular in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 29 (55.77) | 29.6817 |
2010's | 22 (42.31) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Booz, C; Buchner, K; Eichler, K; Frey, N; Gruber-Rouh, T; Gruenewald, LD; Hagenmueller, M; Hardt, SE; Koch, V; Martin, S; März, W; Riffel, JH; Vogl, TJ; Yel, I | 1 |
Gillette, TG; Hill, JA; Jiang, N; Lavandero, S; May, HI; Schiattarella, GG; Tong, D | 1 |
Adamcova, M; Aziriova, S; Balazova, L; Celec, P; Krajcirovicova, K; Pechanova, O; Repova, K; Simko, F; Tothova, L; Vrankova, S; Zorad, S | 1 |
Duan, MX; Liao, HH; Liu, C; Meng, YY; Tang, QZ; Wu, QQ; Xiao, Y; Yang, Z; Yuan, Y | 1 |
Berkban, T; Bunbupha, S; Kukongviriyapan, U; Kukongviriyapan, V; Maneesai, P; Pakdeechote, P; Potue, P; Prachaney, P | 1 |
Chen, J; Huang, C; Huang, Q; Xu, L; Zhang, B | 1 |
Ding, Z; Jiang, S; Li, C; Li, J; Liu, L; Liu, Y; Xie, J; Zhang, X; Zhang, Y; Zhu, W | 1 |
Coelho-Filho, OR; Das, S; Jerosch-Herold, M; Kwong, R; Mitchell, R; Moreno, H; Neilan, TG; Rosenzweig, A; Shah, RV; Simonson, B | 1 |
Ahn, Y; Bae, JW; Cho, AS; Cho, HH; Cho, MC; Hong, MH; Hwang, KK; Jeong, HY; Jeong, MH; Kang, WS; Kim, JS; Kim, YS; Kwon, JS | 1 |
Cacanyiova, S; Drobna, M; Kristek, F | 1 |
Chatterjee, S; Krishna Priya, M; Manivannan, J; Raja, B; Silambarasan, T; Suganya, N | 1 |
Csonka, C; Deten, A; Ferdinandy, P; Pipicz, M; Rebelo, M; Rohrbach, S; Schlüter, KD; Schreckenberg, R; Schulz, R; Weber, M | 1 |
Bunbupha, S; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Prachaney, P; Welbat, JU | 1 |
Fujita, M; Iwasaka, T; Otani, H; Shimazu, T; Shiojima, I; Yoshioka, K | 1 |
Bhimaraj, A; Celis, R; Cordero-Reyes, AM; Estep, JD; Flores-Arredondo, JH; Hamilton, DJ; Orrego, CM; Torre-Amione, G; Trevino, AR; Youker, KA | 1 |
Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y; Sun, S | 1 |
Akita, Y; Iwasaka, T; Matsuhisa, S; Moriguchi, A; Okazaki, T; Otani, H; Sato, D; Yamashita, K | 1 |
Kasal, DA; Mandarim-de-Lacerda, CA; Neves, MF; Oigman, W | 1 |
Akashiba, A; Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y | 1 |
Champlain, Jd; Couture, R; deBlois, D; Huot-Marchand, JE; Pilon, M; Wu, R | 1 |
Baraka, A; El Ghotny, S; Guemei, A; Mikhail, M | 1 |
Erikson, JM; Lao, S; Wilson, BS; Xu, X; Zhang, JQ; Zhao, W | 1 |
Guerrero, MF | 1 |
Adamcova, M; Bednarova, K; Celec, P; Krajcirovicova, K; Palffy, R; Paulis, L; Pechanova, O; Pelouch, V; Simko, F; Vrankova, S | 1 |
Barta, A; Janega, P; Parohova, J; Pechanova, O; Simko, F; Vrankova, S | 1 |
Czabanka, M; Eklund, L; Heljasvaara, R; Ilves, M; Janmey, P; Kerkelä, R; Leskinen, H; Peuhkurinen, K; Pihlajaniemi, T; Piuhola, J; Rasi, K; Ruskoaho, H; Rysä, J; Sormunen, R; Vajkoczy, P; Vuolteenaho, O | 1 |
Baumann, M; Heemann, U; Jianxing, C; Lutz, J; Rusai, K; Schneider, R; Struijker-Boudier, H | 1 |
Akasaki, Y; Araki, S; Hanatani, S; Izumiya, Y; Nakagata, N; Ogawa, H; Rokutanda, T; Takeo, T; Usuku, H; Walsh, K | 1 |
Biwer, LA; Broderick, TL; Carroll, C; Hale, TM; Xu, H | 1 |
Bauer, WR; Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P; Haase, A; Hiller, KH; Hu, K; Nahrendorf, M; Schweizer, G | 1 |
Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Minamino, T; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
Itoh, M; Kubota, I; Miyamoto, T; Shishido, T; Takahashi, H; Takeishi, Y; Tomoike, H | 1 |
Babal, P; Gvozdjakova, A; Krajcirovicova, K; Kucharska, J; Luptak, I; Matuskova, J; Pechanova, O; Simko, F | 1 |
Harada, M; Kitaura, Y; Komuro, I; Masaya, M; Minamino, T; Nagai, T; Sugaya, T; Terasaki, F; Toko, H; Zou, Y | 1 |
Adamy, C; Adubeiro, S; Badoual, T; Bourin, MC; Bourraindeloup, M; Cailleret, M; Candiani, G; Dubois-Rande, JL; Hittinger, L; Pecker, F; Roudot-Thoraval, F; Su, JB | 1 |
Deblois, D; Girardot, D; Jover, B; Moles, JP; Moreau, P | 1 |
Abe, Y; Date, T; Mochizuki, S; Nagai, M; Okada, T; Seki, S; Tanaka, Y; Taniguchi, I; Taniguchi, M | 1 |
Horak, K; Larson, DF; Yu, Q | 1 |
Booz, GW | 1 |
Arai, M; Bao, N; Chen, XH; Fujiwara, H; Kobayashi, H; Maruyama, R; Minatoguchi, S; Misao, Y; Onogi, H; Takemura, G; Uno, Y; Yamaki, T; Yasuda, S | 1 |
Kukreja, RC | 1 |
Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Nakamura, T; Ogawa, H; Tokutomi, Y; Yamamoto, E; Yamashita, T | 1 |
Larson, DF; Rohdewald, PJ; Watson, RR; Yu, Q; Zibadi, S | 1 |
Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F | 1 |
Krajcírovicová, K; Lupták, I; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Pincíková, T; Pomsár, J; Simko, F; Stvrtina, S | 1 |
Chao, J; Chao, L; Yin, H | 1 |
Abbate, A; Brown, WR; Das, A; Hoke, NN; Houser, JE; Kukreja, RC; Mudrick, CA; Prabhakar, S; Qureshi, IZ; Roy, SK; Salloum, FN | 1 |
Chen, JR; Chen, ST; Yang, HY; Yang, SC | 1 |
Hara, K; Higashi, T; Kobayashi, N; Matsuoka, H; Watanabe, S | 1 |
Bernátová, I; Pechánová, O; Pelouch, V; Simko, F | 1 |
Egashira, K; Kitamoto, S; Koyanagi, M; Ni, W; Shimokawa, H; Takeshita, A; Takeya, M; Yoshimura, T | 1 |
Asanuma, H; Hori, M; Kitakaze, M; Kuzuya, T; Minamino, T; Ogai, A; Papst, PJ; Sakata, Y; Terada, N; Ueda, Y | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
[Elements for the effective evaluation of natural products with possible antihypertensive effects].
Topics: Animals; Antihypertensive Agents; Aorta; Biological Products; Blood Pressure; Disease Models, Animal; Drug Evaluation, Preclinical; Hypertension; Medicine, Traditional; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Phytotherapy; Plant Preparations; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Renin-Angiotensin System; Vascular Resistance; Vasodilator Agents; Ventricular Remodeling | 2009 |
51 other study(ies) available for ng-nitroarginine methyl ester and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Homoarginine treatment of rats improves cardiac function and remodeling in response to pressure overload.
Topics: Animals; Blood Pressure; Heart Failure; Homoarginine; Hypertension; Lisinopril; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Spironolactone; Ventricular Remodeling | 2022 |
Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.
Topics: Animals; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose Intolerance; Heart Failure; Humans; Hypertension; Male; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Obesity; Risk Factors; Sex Characteristics; Sex Factors; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling; Weight Gain | 2019 |
Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension; Light; Male; Melatonin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Ventricular Remodeling | 2017 |
Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress.
Topics: Animals; Cell Line; Disease Models, Animal; Echocardiography; Hemodynamics; Immunohistochemistry; In Situ Nick-End Labeling; Iridoid Glucosides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Nitrogen Oxides; Oxidative Stress; Rats; Reactive Oxygen Species; Thioredoxins; Ventricular Remodeling | 2018 |
Hesperidin Prevents Nitric Oxide Deficiency-Induced Cardiovascular Remodeling in Rats via Suppressing TGF-β1 and MMPs Protein Expression.
Topics: Animals; Blood Pressure; Captopril; Gene Expression Regulation; Hesperidin; Male; Matrix Metalloproteinases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Vascular Remodeling; Ventricular Remodeling | 2018 |
The effects of carvedilol on cardiac structural remodeling: the role of endogenous nitric oxide in the activity of carvedilol.
Topics: Animals; Blood Pressure; Carbazoles; Carvedilol; Heart; Hypertension, Renovascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rats; Renal Artery; Ventricular Remodeling | 2013 |
HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism.
Topics: Animals; Apoptosis; Fibrosis; Heart; HSP70 Heat-Shock Proteins; Humans; Mice; Mice, Transgenic; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-bcl-2; Vascular Endothelial Growth Factor A; Ventricular Remodeling | 2013 |
Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
Topics: Algorithms; Animals; Aortic Valve Stenosis; Biomarkers; Body Water; Cardiomyopathy, Hypertrophic; Cell Size; Contrast Media; Gadolinium DTPA; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Mice; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Phenotype; Random Allocation; Ventricular Remodeling | 2013 |
Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Topics: Animals; Enzyme Inhibitors; Female; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-3; Ventricular Remodeling | 2014 |
Different effects of 7-nitroindazole and L-NAME administered both individually and together on the cardiovascular system of the rat.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cardiomegaly; Carotid Arteries; Coronary Vessels; Disease Models, Animal; Enzyme Inhibitors; Heart Ventricles; Hypertension; Indazoles; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats, Inbred SHR; Rats, Wistar; Vascular Remodeling; Vasodilation; Ventricular Remodeling | 2015 |
Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited rats.
Topics: Animals; Anti-Infective Agents; Antioxidants; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Coumaric Acids; Enzyme Inhibitors; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Ventricular Remodeling | 2014 |
Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense.
Topics: Animals; Cells, Cultured; Enzyme Induction; Female; Heart Failure; Homeostasis; Myocardial Contraction; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Oxidation-Reduction; Oxidative Stress; Protective Factors; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Up-Regulation; Ventricular Remodeling | 2015 |
Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Collagen; Disease Models, Animal; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Pentacyclic Triterpenes; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha; Vascular Remodeling; Ventricular Remodeling | 2015 |
Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
Topics: Animals; Aorta; Biopterins; Capillaries; Cell Size; Constriction; Dilatation, Pathologic; Enzyme Inhibitors; Glycine; Heart; Hypertrophy, Left Ventricular; Male; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Oxidative Stress; Pressure; Pterins; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling | 2015 |
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; B-Lymphocytes; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Fibroblasts; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Hypertrophy, Left Ventricular; Immunoglobulin G; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, SCID; Myocardium; NG-Nitroarginine Methyl Ester; Phenotype; Sialic Acid Binding Ig-like Lectin 2; Signal Transduction; Sodium Chloride; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2.
Topics: Animals; Blood Pressure; Fibrosis; Gallic Acid; Heart Ventricles; Histone Deacetylase 1; Histone Deacetylase 2; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Ventricular Remodeling | 2017 |
N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.
Topics: Acetylcysteine; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Benzylamines; Cardiomyopathies; Cricetinae; Drug Interactions; Enzyme Inhibitors; Fibrosis; Free Radical Scavengers; Heart; Heart Ventricles; Losartan; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organ Size; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Ventricular Function, Left; Ventricular Remodeling | 2008 |
Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor.
Topics: Allopurinol; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomyopathies; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Imidazoles; Male; Myocardium; NG-Nitroarginine Methyl Ester; Olmesartan Medoxomil; Rats; Rats, Wistar; Tetrazoles; Time Factors; Uric Acid; Ventricular Remodeling; Xanthine Oxidase | 2008 |
Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Caspase 3; Fibrosis; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; RNA; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan; Ventricular Remodeling | 2008 |
Effect of chronic inhibition of nitric oxide on hypertension, insulin resistance, and cardiovascular remodeling in glucose-fed rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Diet; Epinephrine; Glucose; Hypertension; Hypertrophy; Insulin Resistance; Male; Muscle, Smooth, Vascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Ventricular Remodeling | 2009 |
Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats.
Topics: Animals; Blood Pressure; Caspase 3; Drug Delivery Systems; Fluorobenzenes; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Male; Myocardium; NG-Nitroarginine Methyl Ester; p38 Mitogen-Activated Protein Kinases; Papillary Muscles; Pyrimidines; Random Allocation; Rats; Rosuvastatin Calcium; Sulfonamides; Tretinoin; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2009 |
Effects of exercise and L-arginine on ventricular remodeling and oxidative stress.
Topics: Animals; Arginine; Echocardiography; Enzyme Inhibitors; Free Radicals; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Oxidative Stress; Physical Conditioning, Animal; Polymerase Chain Reaction; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sequence Analysis, DNA; Survival Analysis; Ventricular Remodeling | 2010 |
Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Light; Male; Melatonin; NG-Nitroarginine Methyl Ester; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Ventricular Remodeling | 2010 |
Effect of nuclear factor kappa B inhibition on L-NAME-induced hypertension and cardiovascular remodelling.
Topics: Acetylcysteine; Animals; Blood Pressure; Hypertension; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Ventricular Remodeling | 2010 |
Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy.
Topics: Age Factors; Aging; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomyopathies; Collagen; Coronary Circulation; Disease Models, Animal; Echocardiography; Elasticity; Enzyme Inhibitors; Extracellular Matrix; Female; Gene Expression Profiling; Gene Expression Regulation; Genotype; Heart Ventricles; Hemodynamics; Hypertension; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microscopy, Electron; Microscopy, Video; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Polymerase Chain Reaction; RNA, Messenger; Telemetry; Ventricular Remodeling | 2010 |
Renin inhibition mitigates anti-angiogenesis in spontaneously hypertensive rats.
Topics: Amides; Angiopoietin-1; Angiopoietin-2; Animals; Antihypertensive Agents; Blood Pressure; Capillaries; Fumarates; Hypertension; Male; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Signal Transduction; Ventricular Remodeling | 2011 |
Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction.
Topics: Animals; Enzyme Inhibitors; Fibroblast Growth Factor 1; Heart Ventricles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Animal; Muscle, Skeletal; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left; Ventricular Remodeling | 2012 |
Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Pressure; Cardiac Output; Coronary Circulation; Drug Interactions; Enalapril; Enzyme Inhibitors; Heart Diseases; Heart Function Tests; Heart Rate; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Time Factors; Ventricular Remodeling | 2013 |
Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study.
Topics: Animals; Disease Models, Animal; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridines; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2002 |
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiomegaly; Chromans; Hydralazine; Mitogen-Activated Protein Kinases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Rats; Rats, Inbred WKY; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Ventricular Remodeling | 2003 |
Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits.
Topics: Animals; Cardiac Output; Disease Progression; Enzyme Inhibitors; Hemodynamics; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Random Allocation; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Coenzymes; DNA; Enzyme Inhibitors; Fibrosis; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar; Simvastatin; Ubiquinone; Ventricular Remodeling | 2004 |
Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.
Topics: Angiotensin II; Animals; Arterioles; Capillaries; Chemotaxis, Leukocyte; Collateral Circulation; Cytokines; Enzyme Inhibitors; Granulocytes; Macrophages; Male; Mice; Mice, Knockout; Myocardial Infarction; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Sarcoma 180; T-Lymphocytes; Ventricular Remodeling | 2004 |
N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Collagen; Disease Progression; Drug Evaluation, Preclinical; Glutathione; Heart Ventricles; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Wistar; Sodium Chloride, Dietary; Sphingomyelin Phosphodiesterase; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling | 2004 |
Chronic nitric oxide synthase inhibition prevents new coronary capillary generation.
Topics: Administration, Oral; Animals; Aorta; Blood Pressure; Body Mass Index; Body Weight; Capillaries; Cardiac Volume; Cardiomyopathy, Hypertrophic; Coronary Vessels; Drug Administration Schedule; Drug Therapy, Combination; Heart; Heart Ventricles; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Penicillamine; Rats; Rats, Wistar; Ventricular Remodeling | 2004 |
Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Bradykinin; Coronary Circulation; Echocardiography; Enzyme Inhibitors; Fibrosis; Hypertension, Renal; Hypertrophy, Left Ventricular; Male; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ventricular Remodeling | 2004 |
Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling.
Topics: Amino Acid Oxidoreductases; Animals; Collagen; Disease Models, Animal; Extracellular Matrix; Female; Gene Expression; Hypertension; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; NG-Nitroarginine Methyl Ester; Species Specificity; T-Lymphocytes; Ventricular Function, Left; Ventricular Remodeling | 2006 |
Impact of T lymphocytes on cardiac remodeling in hypertension: more questions than answers.
Topics: Animals; Hypertension; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; NG-Nitroarginine Methyl Ester; Species Specificity; T-Lymphocytes; Ventricular Function, Left; Ventricular Remodeling | 2006 |
Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Topics: Animals; Antipyrine; Blood Pressure; Edaravone; Enzyme Inhibitors; Free Radical Scavengers; Gentisates; Heart Rate; Hydroxybenzoates; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Rabbits; Superoxides; Ventricular Remodeling | 2006 |
Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Carbolines; Cardiomyopathies; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Doxorubicin; Endothelium, Vascular; Enzyme Inhibitors; Erectile Dysfunction; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Imidazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents; Ventricular Remodeling | 2007 |
Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency.
Topics: Animals; Apoptosis; Blood Pressure; Cardiomegaly; Chemokine CCL2; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Macrophages; MAP Kinase Kinase Kinase 5; Mice; Mice, Knockout; Muscle Cells; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrogen Oxides; Superoxides; Transforming Growth Factor beta; Ventricular Remodeling | 2007 |
Impact of Pycnogenol on cardiac extracellular matrix remodeling induced by L-NAME administration to old mice.
Topics: Aging; Animals; Blood Pressure; Collagen; Cross-Linking Reagents; Enzyme Inhibitors; Extracellular Matrix; Flavonoids; Heart; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; RNA; Ventricular Remodeling | 2007 |
Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
Topics: Animals; Arginine; Blood Pressure; Collagen; Hypertension; Hypertrophy, Left Ventricular; Male; Mineralocorticoid Receptor Antagonists; Muscle Proteins; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Spironolactone; Ventricular Remodeling | 2007 |
Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cell Proliferation; DNA Replication; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Remodeling | 2007 |
Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.
Topics: Adenoviridae; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Enzyme Inhibitors; Gene Expression; Gene Transfer Techniques; Heart Function Tests; Heart Ventricles; Hemodynamics; Humans; Kallikreins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocarditis; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Wistar; Receptor, Bradykinin B2; Ventricular Remodeling | 2008 |
Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.
Topics: Animals; Apoptosis; Blotting, Western; Cardiomegaly; Cardiomyopathy, Restrictive; Coronary Vessels; Echocardiography, Doppler; Enzyme Inhibitors; In Situ Nick-End Labeling; Ligation; Male; Mice; Mice, Inbred ICR; Myocardial Infarction; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Piperazines; Pulmonary Edema; Purines; Sildenafil Citrate; Sulfones; Survival Analysis; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2008 |
Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with L-NAME-induced hypertension.
Topics: Alanine Transaminase; Animals; Aorta; Aspartate Aminotransferases; Blood Pressure; Hydrolysis; Hypertension; Lipids; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitrites; Rats; Rats, Wistar; Soybean Proteins; Ventricular Remodeling | 2008 |
Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Disease Models, Animal; DNA Primers; Gene Expression; Heart Ventricles; Hypertension; Imidazoles; Imidazolidines; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Remodeling | 2000 |
Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Collagen; DNA; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Muscle Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Renin-Angiotensin System; RNA; Ventricular Remodeling | 2000 |
Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis.
Topics: Animals; Antibodies, Monoclonal; Blood Pressure; Cell Division; Chemokine CCL2; Chronic Disease; Collagen; Coronary Artery Disease; Dermis; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Inflammation; Male; Monocytes; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Rats; Rats, Inbred WKY; Recombinant Proteins; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2000 |
Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Coronary Vessels; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Hydralazine; Imidazoles; Imidazolidines; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred WKY; Ribosomal Protein S6 Kinases; Sirolimus; Ventricular Remodeling | 2000 |